#Life Sciences
34 articles with this tag
TetraScience Unlocks Biopharma AI
TetraScience partners with Databricks to transform biopharma R&D by making lab data AI-ready, slashing development times and accelerating drug discovery.
Bayer Consumer Health Unifies Data with Databricks
Bayer Consumer Health leverages Databricks and Unity Catalog to create a unified, governed data platform, enabling global self-service analytics and eliminating data silos.
Agentic AI Life Sciences: Reshaping Enterprise Cognition
Salesforce Agentic AI Transforms Life Sciences with Agentforce
AI Agents That Unlock Regulated Life Sciences Workflows with LogicFlo AI
Medical information response times have shortened from one or two weeks to just days.
Superlab Suisse to Open New Facility at Campus Biotech in Geneva in January 2026
Superlab Suisse's new facility caters to a high concentration of life sciences research and entrepreneurship.
Kyron.bio Raises €5.5M to Advance Glycan-Engineered Drug Design
\n Biotech startup kyron.bio has raised €5.5 million in seed funding to develop its proprietary platform for precise glycan engineering, aiming to improve the s...
Kyron.bio Raises €5.5M to Advance Glycan-Engineered Drug Design
\n Biotech startup kyron.bio has raised €5.5 million in seed funding to develop its proprietary platform for precise glycan engineering, aiming to improve the s...
Biostate AI Raises $12M Series A to Power GenAI for Molecular Diagnostics
<p>Accel leads investment to scale RNA sequencing platform that predicts disease and treatment response using generative AI.</p>
MaxisIT Evolves to Maxis AI, Launches Enterprise-Ready Agentic AI Platform to Transform Clinical Trials in Pharmaceutical and Life Sciences Industry
Cradle Accelerates Biotech with Generative AI and $73M
Converge Bio Raises $5.5M for Biotech LLMs
<p>$5.5 million in a seed round led by TLV Partners.</p><p>Converge Bio leverages open-source foundation models while developing proprietary processes.</p>
Converge Bio Raises $5.5M for Biotech LLMs
Converge Bio secured $5.5 million in seed funding, led by TLV Partners, to expand its platform that enhances the utility of biology-focused large language model...
Dante Genomics Launches Generative AI Powered Genomics Interpretation and Consultation
\n Dante Genomics , a leader in genomics and personalized medicine, has announced the integration of Generative AI into its flagship product, the Dante Labs Who...
Dante Genomics Launches Generative AI Powered Genomics Interpretation and Consultation
<p>Genomic data analysis using a proprietary platform based on artificial intelligence and machine learning.</p><p>Dante Labs Whole Genome platform with GenAI features will be available globally starting Q1 2025.</p>
Upstream Bio IPOs at $830M Valuation, Raises $255M, Advances Respiratory Treatments
Triomics Raises $15M to Automate Oncology Workflows with GenAI Platform
Nectin Therapeutics Secures $10 Million from GIBF to Propel Immunotherapy
IAG Capital Partners Leads $24M in Generative AI Startup for Drug Discovery, DeepCure
C2i Genomics Acquired for $95 Million by Veracyte
Accenture Ventures Backs QuantHealth, Clinical Trial Simulations
9xchange Partners with PhaseV on Causal Machine Learning Clinical Trial Optimization
PhaseV Nabs $15 Million Funding for ML Clinical Trial Optimization
Mana.bio Raises $14.5 Million Funding to Revolutionize AI Drug Delivery
\n Israeli AI biotechnology startup, Mana.bio , announced the raising of an additional $14.5 million for their Seed funding round.
Mana.bio Raises $14.5 Million Funding to Revolutionize AI Drug Delivery
\n Israeli AI biotechnology startup, Mana.bio , announced the raising of an additional $14.5 million for their Seed funding round.
Advancing Neurotoxicity Research with INTEGRA Biosciences Pipettes
\n INTEGRA Biosciences has awarded 31 EVOLVE manual pipettes, GRIPTIPS® pipette tips worth US $1000, and lab accessories to the bioanalytical company DNTOX as p...
Advancing Neurotoxicity Research with INTEGRA Biosciences Pipettes
\n INTEGRA Biosciences has awarded 31 EVOLVE manual pipettes, GRIPTIPS® pipette tips worth US $1000, and lab accessories to the bioanalytical company DNTOX as p...
ViAqua Therapeutics Secures $8.25 Million in Funding for Shellfish Disease Management
\n ViAqua Therapeutics , an Israel-based biotechnology startup specializing in aquaculture health, secured an $8.25 million funding round.
ViAqua Therapeutics Secures $8.25 Million in Funding for Shellfish Disease Management
\n ViAqua Therapeutics , an Israel-based biotechnology startup specializing in aquaculture health, secured an $8.25 million funding round.
US Venture Firm General Catalyst and Israel's Sheba Medical Center Boost Digital Health Tech
Mileutis Showcases Revolutionary Dairy Industry Solution at Stifel 2023 Jaws & Paws Conference
AI-Driven Patient Finder Analysis Launched by Verix on Tovana Platform
Immunai and Baylor College of Medicine Unveil BTG1 as New Molecular Target to Boost Cancer Immunotherapy
